Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(2.89)
# 2,714
Out of 4,444 analysts
52
Total ratings
50%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Downgraded: Hold | $55 → $40 | $43.20 | -7.41% | 8 | Jun 23, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $20 | $14.13 | +41.54% | 3 | Jun 5, 2026 | |
| NTRA Natera | Maintained: Buy | $250 → $270 | $259.97 | +3.86% | 7 | May 8, 2026 | |
| PODD Insulet | Maintained: Buy | $240 → $200 | $148.88 | +34.34% | 4 | May 7, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $58.88 | -15.07% | 6 | May 7, 2026 | |
| RGEN Repligen | Rated: Buy | $170 → $140 | $138.40 | +1.16% | 8 | Apr 6, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $170 → $118 | $77.62 | +52.03% | 5 | Apr 6, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $69.75 | -2.51% | 1 | Nov 26, 2025 | |
| GH Guardant Health | Maintained: Buy | $68 → $90 | $136.96 | -34.29% | 4 | Oct 30, 2025 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $340.41 | - | 6 | Oct 27, 2025 |
Inspire Medical Systems
Jun 23, 2026
Downgraded: Hold
Price Target: $55 → $40
Current: $43.20
Upside: -7.41%
MiniMed Group
Jun 5, 2026
Maintained: Buy
Price Target: $20
Current: $14.13
Upside: +41.54%
Natera
May 8, 2026
Maintained: Buy
Price Target: $250 → $270
Current: $259.97
Upside: +3.86%
Insulet
May 7, 2026
Maintained: Buy
Price Target: $240 → $200
Current: $148.88
Upside: +34.34%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $58.88
Upside: -15.07%
Repligen
Apr 6, 2026
Rated: Buy
Price Target: $170 → $140
Current: $138.40
Upside: +1.16%
TransMedics Group
Apr 6, 2026
Maintained: Buy
Price Target: $170 → $118
Current: $77.62
Upside: +52.03%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $69.75
Upside: -2.51%
Guardant Health
Oct 30, 2025
Maintained: Buy
Price Target: $68 → $90
Current: $136.96
Upside: -34.29%
West Pharmaceutical Services
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $340.41
Upside: -